hrp0086p1-p928 | Thyroid P1 | ESPE2016

Preliminary Results: Body Composition of Adolescent Patients with Congenital Hypothyroidism and Correlation with Laboratory Parameters

Doulgeraki Artemis , Petrocheilou Glykeria , Polyzois Georgios , Tsoka Eleni

Background: Thyroid dysfunction may predispose to imbalanced body composition.Objective and hypotheses: The aim of the study is to evaluate bone, muscle and fat mass in teenagers with congenital hypothyroidism and correlate their bone profile with laboratory parameters, in an effort to offer more effective lifestyle counselling.Method: Adolescents diagnosed with congenital hypothyroidism through neonatal screening underwent thoroug...

hrp0098p2-41 | Bone, Growth Plate and Mineral Metabolism | ESPE2024

Linear growth in children and adolescents treated with zoledronic acid (ZA): A Single Institution Case Series

Bonataki Myrto , Doulgeraki Artemis , Papadopoulou Aikaterini-Kydonia , Polyzois Georgios , Athanasopoulou Helen , Vlachopapadopoulou Elpis-Athina

Introduction: Intravenously given bisphosphonates are the treatment of choice for pediatric osteoporosis. As bone resorption is an essential part of the normal endochondral ossification process, there were concerns on the possible negative impact of bisphosphonates on longitudinal growth during childhood. The aim of this study is to report the impact of zoledronic acid (ZA) on height in pediatric patients with primary osteoporosis.<stron...

hrp0086p2-p148 | Bone &amp; Mineral Metabolism P2 | ESPE2016

A Preliminary Report on Body Composition Profile of Young Patients with Chronic Hemolytic Conditions

Doulgeraki Artemis , Chatziliami Antonia , Athanasopoulou Helen , Polyzois Georgios , Petrocheilou Glykeria , Iousef Jacqueline , Karabatsos Fotis , Schiza Vasiliki , Fragodimitri Christina

Background: Chronic hemolytic anemias may compromise growth through multiple mechanisms. To date, no data exist on growth and body composition (BC; bone, muscle and fat mass) of children and adolescents with chronic hemolysis.Purpose: To evaluate growth and BC of patients with thalassemia intermedia (not on regular transfusions; thal-intermedia), alpha-thalassemia and congenital spherocytosis....